Gut liver brain axis in diseases: the implications for therapeutic interventions
M Yan, S Man, B Sun, L Ma, L Guo, L Huang… - Signal Transduction and …, 2023 - nature.com
Gut-liver-brain axis is a three-way highway of information interaction system among the
gastrointestinal tract, liver, and nervous systems. In the past few decades, breakthrough …
gastrointestinal tract, liver, and nervous systems. In the past few decades, breakthrough …
[HTML][HTML] A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
S Zhou, H You, S Qiu, D Yu, Y Bai, J He, H Cao… - Biomedicine & …, 2022 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is primarily caused by abnormal lipid metabolism
and the accumulation of triglycerides in the liver. NAFLD is also associated with hepatic …
and the accumulation of triglycerides in the liver. NAFLD is also associated with hepatic …
Bile formation and secretion: an update
JL Boyer, CJ Soroka - Journal of hepatology, 2021 - Elsevier
Bile formation is a fundamental physiological process that is vital to the survival of all
vertebrates. However, little was known about the mechanisms of this secretion until after …
vertebrates. However, little was known about the mechanisms of this secretion until after …
Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1
Two common features of dietary polyphenols have hampered our mechanistic
understanding of their beneficial effects for decades: targeting multiple organs and …
understanding of their beneficial effects for decades: targeting multiple organs and …
therapeutic aspects of bile acid signalling in the gut‐liver axis
B Simbrunner, M Trauner… - Alimentary Pharmacology …, 2021 - Wiley Online Library
Background Bile acids are important endocrine modulators of intestinal and hepatic
signalling cascades orchestrating critical pathophysiological processes in various liver …
signalling cascades orchestrating critical pathophysiological processes in various liver …
Bile acid metabolism and signaling: emerging pharmacological targets of dietary polyphenols
KM Tveter, E Mezhibovsky, Y Wu… - Pharmacology & …, 2023 - Elsevier
Beyond their role as emulsifiers of lipophilic compounds, bile acids (BAs) are signaling
endocrine molecules that show differential affinity and specificity for a variety of canonical …
endocrine molecules that show differential affinity and specificity for a variety of canonical …
Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation
Organic cation transporters (OCT), organic anion transporting polypeptides (OATP) and
organic anion transporters (OAT) from the solute carrier (SLC) family play an essential role …
organic anion transporters (OAT) from the solute carrier (SLC) family play an essential role …
Discovery of the first-in-class intestinal restricted FXR and FABP1 dual modulator ZLY28 for the treatment of nonalcoholic fatty liver disease
Q Ren, Y Chen, Z Zhou, Z Cai, S Jiao… - Journal of Medicinal …, 2023 - ACS Publications
The prevalence of nonalcoholic steatohepatitis (NASH) is increasing rapidly worldwide, and
NASH has become a serious problem for human health. Recently, the selective activation of …
NASH has become a serious problem for human health. Recently, the selective activation of …
[PDF][PDF] Targeting the four pillars of enterohepatic bile salt cycling; lessons from genetics and pharmacology
RF Kunst, HJ Verkade, RPJ Oude Elferink… - …, 2021 - Wiley Online Library
Bile salts play a pivotal role in lipid homeostasis, are sensed by specialized receptors, and
have been implicated in various disorders affecting the gut or liver. They may play a role …
have been implicated in various disorders affecting the gut or liver. They may play a role …
Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease
W Huang, Z Cao, W Wang, Z Yang, S Jiao, Y Chen… - Bioorganic …, 2024 - Elsevier
Farnesoid X receptor (FXR) was considered as a promising drug target in the treatment of
cholestasis, drug-induced liver injury, and non-alcoholic steatohepatitis (NASH). However …
cholestasis, drug-induced liver injury, and non-alcoholic steatohepatitis (NASH). However …